{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:19:57Z","timestamp":1792131597727,"version":"4.4.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100021078","name":"Norwegian Institute of Public Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100021078","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>This study forecasts total and cause-specific health expenditures in Norway to 2050 and quantifies the contribution of four key drivers\u2014total population growth, population aging, changes in disease prevalence, and cost per case\u2014on future health care spending.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We forecast spending for 116 health conditions in Norway from 2022 to 2050, using historical and forecasted data of population growth, disease prevalence, gross domestic product (GDP), health spending, and residual factors. Our analysis included a reference scenario that forecasted disease-specific health spending; two alternative scenarios examining the effects of alternative unit cost developments; and a scenario examining the consequences of improved behavioral and metabolic risk factors.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Health spending increased from 10.6% (95% uncertainty interval, 10.2\u201311.1) of GDP in 2022 to 14.3% (13.0\u201315.7) in 2050 in the reference scenario. Among the top aggregate causes of Norwegian health spending in 2022, the spending for neurological disorders rose the most, from 1.7% (1.6\u20131.8) to 2.7% (2.3\u20133.1) of GDP, surpassing mental and substance use disorders which rose from 2.2% (2.1\u20132.3) to 2.4% (2.2\u20132.6) of GDP. Of the 116 single conditions analyzed, dementias accounted for the highest spending in 2022. This expenditure was forecasted to increase considerably from 1.1% (1.09\u20131.2) to 1.9% (1.6\u20132.2) of GDP by 2050, largely due to population aging. Spending on other old-age-related conditions like falls, stroke, and diabetes, was also forecasted to increase. Increased population, aging, and spending per case contributed to increased future spending. Reduced behavioral and metabolic risks were forecasted to increase the number of elderly persons and reduce age-specific disease prevalence but had little impact on forecasted health spending.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Health spending growth was forecasted regardless of the scenario, and Norway needs to plan for this. However, policymakers can curb total spending growth, while maintaining health care quality and output, by ensuring more efficient allocation and effective use of resources. While the overall impact of behavioral and metabolic risk reductions on total healthcare spending was modest, reducing risk factors is needed if countries aim to achieve a healthier, longer-living population.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12916-025-03917-2","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T12:46:13Z","timestamp":1740487573000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Forecasting total and cause-specific health expenditures for 116 health conditions in Norway, 2022\u20132050"],"prefix":"10.1186","volume":"23","author":[{"given":"Jonas Minet","family":"Kinge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"\u00d8ien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph L.","family":"Dieleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f8rn-Atle","family":"Reme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann Kristin Skrindo","family":"Knudsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geir","family":"Godager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geir","family":"Selb\u00e6k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan C.","family":"Frich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enis","family":"Bar\u0131\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J. L.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stein Emil","family":"Vollset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,25]]},"reference":[{"key":"3917_CR1","unstructured":"Schneider EC, Shah A, Doty MM, Tikkanen R, Fields K, Williams R, et al. Reflecting Poorly: Health Care in the US Compared to Other High-Income Countries. New York: The Commonwealth Fund. 2021."},{"issue":"1","key":"3917_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.healthpol.2012.05.001","volume":"107","author":"R Astolfi","year":"2012","unstructured":"Astolfi R, Lorenzoni L, Oderkirk J. Informing policy makers about future health spending: a comparative analysis of forecasting methods in OECD countries. Health Policy. 2012;107(1):1\u201310.","journal-title":"Health Policy"},{"key":"3917_CR3","unstructured":"Lorenzoni L, Marino A, Morgan D, James C. Health spending projections to 2030: New results based on a revised OECD methodology, OECD health working papers. Paris: OECD Publishing; 2019;110."},{"key":"3917_CR4","unstructured":"European Commission. The 2021 Ageing Report. Economic and Budgetary Projections for the EU Member States (2019\u20132070). European Economy Institutional Paper 148. Luxembourg: Publications Office of the European Union; 2021."},{"key":"3917_CR5","unstructured":"NOU. Tid for Handling \u2014 Personellet i En B\u00e6rekraftig Helse- Og Omsorgstjeneste. Oslo, Norway: Helse og Omsorgsdepartementet; 2023;4."},{"issue":"1","key":"3917_CR6","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1071\/AH080148","volume":"32","author":"S Begg","year":"2008","unstructured":"Begg S, Vos T, Goss J, Mann N. An alternative approach to projecting health expenditure in Australia. Aust Health Rev. 2008;32(1):148\u201355.","journal-title":"Aust Health Rev"},{"issue":"10091","key":"3917_CR7","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S0140-6736(17)30818-8","volume":"390","author":"RM Barber","year":"2017","unstructured":"Barber RM, Fullman N, Sorensen RJD, Bollyky T, McKee M, Nolte E, Abajobir AA, Abate KH, Abbafati C, Abbas KM, et al. Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990\u20132015: a novel analysis from the Global Burden of Disease Study 2015. Lancet. 2017;390(10091):231\u201366.","journal-title":"Lancet"},{"issue":"10440","key":"3917_CR8","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1016\/S0140-6736(24)00476-8","volume":"403","author":"AE Schumacher","year":"2024","unstructured":"Schumacher AE, Kyu HH, Aali A, Abbafati C, Abbas J, Abbasgholizadeh R, Abbasi MA, Abbasian M, Abd ElHafeez S, Abdelmasseh M, et al. Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950\u20132021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403(10440):1989\u20132056.","journal-title":"Lancet"},{"key":"3917_CR9","unstructured":"Turner A, Miller G, Lowry E. High US Health Care Spending: Where Is It All Going. New York: The Commonwealth Fund; 2023."},{"key":"3917_CR10","unstructured":"Munira Z. Gunja EDG, Reginald D. Williams II: U.S. Health Care from a Global Perspective, 2022: Accelerating Spending, Worsening Outcomes. New York: The Commonwealth Fund; 2023."},{"issue":"1","key":"3917_CR11","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s12916-023-02896-6","volume":"21","author":"JM Kinge","year":"2023","unstructured":"Kinge JM, Dieleman JL, Karlstad \u00d8, Knudsen AK, Klitkou ST, Hay SI, Vos T, Murray CJ, Vollset SE. Disease-specific health spending by age, sex, and type of care in Norway: a national health registry study. BMC Med. 2023;21(1):201.","journal-title":"BMC Med"},{"issue":"9","key":"3917_CR12","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1001\/jama.2020.0734","volume":"323","author":"JL Dieleman","year":"2020","unstructured":"Dieleman JL, Cao J, Chapin A, Chen C, Li Z, Liu A, Horst C, Kaldjian A, Matyasz T, Scott KW. US health care spending by payer and health condition, 1996\u20132016. JAMA. 2020;323(9):863\u201384.","journal-title":"JAMA"},{"key":"3917_CR13","unstructured":"OECD. OECD Health Statistics\u2014Health Expenditure and Financing. OECD. Paris; 2023. https:\/\/www.oecd.org\/en\/data\/datasets\/oecd-health-statistics.html."},{"key":"3917_CR14","unstructured":"OECD. Demography and poplation. OECD. Paris: 2023. https:\/\/www.oecd.org\/en\/data\/indicators\/population.html."},{"key":"3917_CR15","unstructured":"Global Burden of Disease Collaborative Network. Gross Domestic Product Per Capita 1960-2050. Seattle, United States of America: Institute for Health Metrics and Evaluation (IHME); 2021."},{"key":"3917_CR16","unstructured":"Institute for Health Metrics and Evaluation (IHME). GBD Results. Seattle, WA: IHME, University of Washington; 2024. https:\/\/vizhub.healthdata.org\/gbd-results\/."},{"key":"3917_CR17","unstructured":"OECD. National accounts. OECD. Paris: 2023. https:\/\/www.oecd.org\/en\/about\/programmes\/oecd-data-collection-programme\/national-accounts.html."},{"key":"3917_CR18","unstructured":"Statistics Sweden. System of Health Accounts (SHA). Statistics Sweden. \u00d6rebro; 2023. https:\/\/www.statistikdatabasen.scb.se\/pxweb\/en\/ssd\/START__NR__NR0109\/HCHF\/."},{"key":"3917_CR19","unstructured":"Statistics Norway. Health accounts. Statistics Norway. Oslo; 2023. https:\/\/www.ssb.no\/en\/nasjonalregnskap-og-konjunkturer\/nasjonalregnskap\/statistikk\/helseregnskap."},{"issue":"10440","key":"3917_CR20","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1016\/S0140-6736(24)00685-8","volume":"403","author":"SE Vollset","year":"2024","unstructured":"Vollset SE, Ababneh HS, Abate YH, Abbafati C, Abbasgholizadeh R, Abbasian M, Abbastabar H. Abd Al Magied AH, Abd ElHafeez S, Abdelkader A. Burden of disease scenarios for 204 countries and territories, 2022\u20132050: a forecasting analsysi for the Global Burden of Disease Study. Lancet. 2024;403(10440):2204\u201356.","journal-title":"Lancet"},{"key":"3917_CR21","unstructured":"OECD. Economic Outlook 109 database. OECD. Paris: 2021. https:\/\/www.oecd.org\/en\/publications\/oecd-economic-outlook\/volume-2021\/issue-1_490d4832-en.html."},{"issue":"1","key":"3917_CR22","first-page":"61","volume":"2014","author":"C De la Maisonneuve","year":"2015","unstructured":"De la Maisonneuve C, Martins JO. The future of health and long-term care spending. OECD Journal: Economic Studies. 2015;2014(1):61\u201396.","journal-title":"OECD Journal: Economic Studies"},{"key":"3917_CR23","unstructured":"Dybczak K, Przywara B. The role of technology in health care expenditure in the EU. In.: Directorate General Economic and Financial Affairs, European Commission; 2010."},{"key":"3917_CR24","unstructured":"Grignon M. SB, Wang L. Model of Long-Term Health Care Cost Trends in Canada. In.: Canadian Institute of Actuaries and the Society of Actuaries 2018."},{"issue":"1","key":"3917_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00181-022-02246-0","volume":"64","author":"J Costa-Font","year":"2023","unstructured":"Costa-Font J, Vilaplana-Prieto C. \u2018Investing\u2019in care for old age? An examination of long-term care expenditure dynamics and its spillovers. Empirical Economics. 2023;64(1):1\u201330.","journal-title":"Empirical Economics"},{"issue":"1","key":"3917_CR26","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0167-6296(01)00122-9","volume":"21","author":"AA Okunade","year":"2002","unstructured":"Okunade AA, Murthy VN. Technology as a \u2018major driver\u2019of health care costs: a cointegration analysis of the Newhouse conjecture. J Health Econ. 2002;21(1):147\u201359.","journal-title":"J Health Econ"},{"issue":"4","key":"3917_CR27","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0167-6296(99)00036-3","volume":"19","author":"U-G Gerdtham","year":"2000","unstructured":"Gerdtham U-G, L\u00f6thgren M. On stationarity and cointegration of international health expenditure and GDP. J Health Econ. 2000;19(4):461\u201375.","journal-title":"J Health Econ"},{"key":"3917_CR28","doi-asserted-by":"crossref","unstructured":"Feng Y, Watt T, Charlesworth A, Marsden G, Roberts A, Sussex J. What Determines the Health Care Expenditure of High Income Countries? A Dynamic Estimation. Applied Economics and Finance. 2017.","DOI":"10.11114\/aef.v4i6.2586"},{"key":"3917_CR29","doi-asserted-by":"crossref","unstructured":"Thompson Jr W. The problem of negative estimates of variance components. The Annals of Mathematical Statistics. 1962:273\u2013289.","DOI":"10.1214\/aoms\/1177704731"},{"key":"3917_CR30","doi-asserted-by":"crossref","unstructured":"De la Maisonneuve C, Oliveira Martins J. A projection method for public health and long-term care expenditures. OECD Economics Department Working Papers, No. 1048. Paris: OECD Publishing; 2013.","DOI":"10.2139\/ssrn.2291541"},{"issue":"8","key":"3917_CR31","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.jval.2020.05.006","volume":"23","author":"M Perry-Duxbury","year":"2020","unstructured":"Perry-Duxbury M, Asaria M, Lomas J, van Baal P. Cured today, ill tomorrow: a method for including future unrelated medical costs in economic evaluation in England and Wales. Value in Health. 2020;23(8):1027\u201333.","journal-title":"Value in Health"},{"key":"3917_CR32","doi-asserted-by":"crossref","unstructured":"Baumol WJ. Health care, education and the cost disease: A looming crisis for public choice. In: The next twenty-five years of public choice. edn.: Dordrecht: Springer Netherlands; 1993. p. 17\u201328.","DOI":"10.1007\/978-94-017-3402-8_3"},{"key":"3917_CR33","unstructured":"Heffler S, Caldis, TG., Smith, SD., Cuckler, GA. The Long-Term Projection Assumptions for Medicare and Aggregate National Health Expenditures. In. Edited by SERVICES DOHAH. Baltimore, MD: Centers for Medicare Medicaid Services."},{"key":"3917_CR34","unstructured":"Wooldridge JM. Introductory Econometrics: A Modern Approach 3rd ed. Mason, Ohio: Thomson South-Western; 2006."},{"key":"3917_CR35","unstructured":"Das Gupta P. Standardization and decomposition of rates: A user's manual, U.S. Bureau of the Census, Current Population Reports, Series P23-186, U.S. Washington, DC: Government Printing Office; 1993."},{"issue":"17","key":"3917_CR36","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1001\/jama.2017.15927","volume":"318","author":"JL Dieleman","year":"2017","unstructured":"Dieleman JL, Squires E, Bui AL, Campbell M, Chapin A, Hamavid H, Horst C, Li Z, Matyasz T, Reynolds A. Factors associated with increases in US health care spending, 1996\u20132013. JAMA. 2017;318(17):1668\u201378.","journal-title":"JAMA"},{"key":"3917_CR37","doi-asserted-by":"crossref","unstructured":"Drummond ME, Sculpher MJ, Torrance GW, O\u2019Brien BJ, Stoddart GL. Methods for the Economic Evaluation of Health Care Programmes. Oxford, United Kingdom: Oxford Univesity press; 2005.","DOI":"10.1093\/oso\/9780198529446.001.0001"},{"key":"3917_CR38","unstructured":"Lewis CD. Industrial and business forecasting methods: A practical guide to exponential smoothing and curve fitting. London: Butterworths; 1982."},{"key":"3917_CR39","unstructured":"OECD. Long-term baseline projections, No. 114. In. Edited by OECD. Paris; 2023."},{"key":"3917_CR40","unstructured":"Saltman R, Busse R, Figueras J. Decentralization in health care: strategies and outcomes: McGraw-Hill Education (UK), Berkshire, England; 2006."},{"issue":"5","key":"3917_CR41","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1111\/1475-6773.01112","volume":"37","author":"R Lee","year":"2002","unstructured":"Lee R, Miller T. An approach to forecasting health expenditures, with application to the US Medicare system. Health Serv Res. 2002;37(5):1365\u201386.","journal-title":"Health Serv Res"},{"key":"3917_CR42","doi-asserted-by":"publisher","first-page":"106212","DOI":"10.1016\/j.econmod.2023.106212","volume":"121","author":"K Mino","year":"2023","unstructured":"Mino K, Sasaki H. Long-run consequences of population decline in an economy with exhaustible resources. Econ Model. 2023;121:106212.","journal-title":"Econ Model"},{"issue":"8","key":"3917_CR43","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1080\/13504850010017357","volume":"8","author":"N Devlin","year":"2001","unstructured":"Devlin N, Hansen P. Health care spending and economic output: Granger causality. Appl Econ Lett. 2001;8(8):561\u20134.","journal-title":"Appl Econ Lett"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-025-03917-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-025-03917-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-025-03917-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T12:46:21Z","timestamp":1740487581000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-025-03917-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,25]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3917"],"URL":"https:\/\/doi.org\/10.1186\/s12916-025-03917-2","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,25]]},"assertion":[{"value":"22 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The microdata used for the Norwegian Health Spending Project was approved, and participant consent was waived, by the Regional Committee for Medical and Health Research Ethics South-East Norway, reference number 184544.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"GS has received honoraria for giving lectures at symposia sponsored by Eisai and Eli-Lilly.\u00a0GS had participated at advisory boards for Eisai and Eli-Lilly concerning anti-amyloid treatment in Alzheimer\u2019s disease.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"116"}}